ADUHELM® (aducanumab-avwa) | Official Patient Site
WEBADUHELM is indicated for the treatment of Alzheimer’s disease. ADUHELM should be started in patients with mild cognitive impairment or mild dementia stage of disease, the population studied in clinical trials.
Safety | ADUHELM® (aducanumab-avwa) | Patient Site
WEBADUHELM can cause serious side effects, including: See above “What is the most important information I should know about ADUHELM?” Serious allergic reactions. Swelling of the face, lips, mouth, or tongue and hives have happened during an ADUHELM infusion.
Indication and Safety Info | ADUHELM® (aducanumab-avwa)
WEBINDICATION. ADUHELM is indicated for the treatment of Alzheimer’s disease. ADUHELM should be started in patients with mild cognitive impairment or mild dementia stage of disease, the population studied in clinical trials.
en-us - ADUHELM
WEBAbout ADUHELM Safety and Side Effects Biogen Support Services for Patients Biogen Support Services for Patients 1-833-425-9360. Prescribing Information; Medication Guide; Important Safety Information; View Healthcare Professionals Site; 1-833-425-9360; Prescribing Information ...